Chief Executive Officer,
Paul Grand is CEO of MedTech Innovator, the premier nonprofit global accelerator for medical technology and the largest accelerator of medical devices in the world. He has an extensive global network in transformative medical innovation. Funded by and in partnership with 20 leading corporate partners, nonprofits and federal agencies, MedTech Innovator identifies the most promising medtech startups around the world and connects them with stakeholders for mentorship and funding to ensure that transformative technologies reach patients and improve lives. Graduates have brought more than 100 products to market and raised over $4B in follow-on funding.
Prior to MedTech Innovator, Grand was Managing Director at RCT Ventures, an early-stage life science investor since 2005. At RCT, Grand focused on medtech investments and sourcing innovation. He founded MedTech Innovator as a program within RCT Ventures in 2013, and he left to run MedTech Innovator as a stand-alone company with RCT's support in 2016.
Prior to RCT, Grand was an entrepreneur, founding and / or serving as CEO in eight companies in life sciences and technology, including most recently Imagine Pharmaceuticals, which developed a platform to deliver therapeutics across the blood brain barrier and MicroSurgeon, which developed a thermal ablation device treating solid tumors.
Grand is actively involved in programs to encourage healthcare innovation. He has lectured and mentored students & scientists at numerous universities, including UCLA, Stanford, USC, and UCSF. Grand served as an investment advisor to the LARTA NIH Commercialization Assistance Program for SBIR awardees. He served on the Oversight Committees for the Coulter Translational Research Partnership Programs at USC and University of Washington. Grand has reviewed proof of concept and commercialization-focused funding programs for the University of California, USC, University of Utah, and University of Colorado.
Grand is a frequent panelist at healthcare conferences. He has spoken at more than 100 conferences, been featured in hundreds of articles in publications including Forbes, New York Times and Wall Street Journal and appeared as an expert on Bloomberg Television, CNN, and CNN/FN.